Replies to post #6969 on Amarin Corp Plc (AMRN)

[Biobillionair]

At this point it's irrelevant. The FDA has proven incompetence, and NCE has no value over NME for Anchor.
Patent's have NEVER expired with NCE/NME, Amarin dominates until 2030. 17 years of Billions + revenue...
Williams